Investigational sleep peptide
DSIP
Prepared by the ezGLP team. Sources last checked .
Also known as Delta sleep-inducing peptide, Emideltide
Routes represented in the knowledgebase: Intranasal / Subcutaneous (SubQ).
Educational overview
Not FDA-approved; human evidence and safety information are very limited, with peptide impurity and immunogenicity concerns.
- Category
- Investigational sleep peptide
- Routes represented
- Intranasal / Subcutaneous (SubQ)
- Storage context
- Follow the dispensed product or pharmacy label; storage and beyond-use time vary by formulation.
Published literature
No validated PubMed or DOI link is currently curated for this entry.
Safety evidence
Serious or important: potential immunogenicity, aggregation, impurity, or product-quality risks.
A dependable route-specific human interaction and side-effect profile is not established; this is not evidence of no risk.
Safety evidence sourceSummarised from published literature for reference only, with citations to the source. Evidence is graded as reported and is not a recommendation to combine, dose, or use any compound.
For personal tracking and education only. Not medical advice, diagnosis, or treatment, and not a medical device. Peptides may be prescription-only or unapproved where you live — consult a licensed healthcare professional.